Israel Englander’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.9M Sell
268,324
-444,241
-62% -$10.3M ﹤0.01% 2682
2026
Q1
$14.7M Buy
712,565
+9,821
+1% +$221K 0.01% 1808
2025
Q4
$16.7M Buy
702,744
+112,428
+19% +$2.74M 0.01% 1746
2025
Q3
$14.7M Sell
590,316
-210,744
-26% -$4.54M 0.01% 2002
2025
Q2
$18.4M Buy
801,060
+455,149
+132% +$10.5M 0.01% 1654
2025
Q1
$7.77M Sell
345,911
-117,694
-25% -$2.73M ﹤0.01% 2439
2024
Q4
$9.06M Buy
463,605
+69,198
+18% +$1.37M ﹤0.01% 2282
2024
Q3
$7.18M Sell
394,407
-744,119
-65% -$14.2M ﹤0.01% 2508
2024
Q2
$19.8M Buy
1,138,526
+1,101,730
+2,994% +$19.5M 0.01% 1509
2024
Q1
$721K Sell
36,796
-390,974
-91% -$8.26M ﹤0.01% 4564
2023
Q4
$9.85M Buy
427,770
+97,901
+30% +$2.19M ﹤0.01% 2200
2023
Q3
$7.59M Buy
329,869
+118,560
+56% +$3.01M ﹤0.01% 2316
2023
Q2
$5.52M Sell
211,309
-296,973
-58% -$7.84M ﹤0.01% 2586
2023
Q1
$14M Sell
508,282
-2,487,790
-83% -$65.7M 0.01% 1644
2022
Q4
$68M Buy
2,996,072
+1,940,218
+184% +$54M 0.04% 562
2022
Q3
$36M Buy
1,055,854
+315,521
+43% +$11.7M 0.02% 888
2022
Q2
$21.6M Sell
740,333
-559,420
-43% -$14.2M 0.01% 1235
2022
Q1
$34.7M Buy
1,299,753
+87,793
+7% +$2.07M 0.02% 921
2021
Q4
$31.4M Buy
1,211,960
+525,401
+77% +$13.1M 0.02% 1057
2021
Q3
$16.2M Buy
686,559
+642,397
+1,455% +$22.4M 0.01% 1532
2021
Q2
$1.96M Buy
+44,162
New +$1.63M ﹤0.01% 3993

Other funds holding PRVA

Israel Englander's PRVA Position: Q2 2026 in Review

Israel Englander reduced its Privia Health (PRVA) stake by 62% in Q2 2026, selling an estimated $10.3M and leaving 268,324 shares worth $6.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

Israel Englander first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $68M in Q4 2022. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Israel Englander held 268,324 shares of Privia Health worth $6.9M as of Q2 2026.
  • Israel Englander sold 444,241 Privia Health shares in Q2 2026, an estimated $10.3M.
  • Privia Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2682 holding.
  • Israel Englander first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Israel Englander's Privia Health position peaked at $68M in Q4 2022.
  • 300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.